This inventor holds 1 USPTO granted patent. Top assignee: Saint Louis University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Chelsea DeLeon: Innovator in Cancer Treatment
Introduction
Chelsea DeLeon is a prominent inventor based in Saint Louis, MO (US). She has made significant contributions to the field of medical research, particularly in the treatment of cancers and calcium disorders. Her innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Chelsea holds a patent for "Compounds and methods targeting GPER in calcium disorders." This patent provides compositions and methods targeting GPER for the treatment of various cancers, including breast cancers and leukemias, as well as gallstone disease. Additionally, her work focuses on conferring neuroprotection on subjects. The patent also discloses high throughput assays for identifying antagonists of GPER, showcasing her commitment to advancing medical science.
Career Highlights
Chelsea is affiliated with Saint Louis University, where she conducts her research and collaborates with other professionals in the field. Her dedication to innovation and research has positioned her as a key figure in her area of expertise.
Collaborations
Chelsea collaborates with Christopher Arnatt, further enhancing her research capabilities and expanding the impact of her work.
Conclusion
Chelsea DeLeon is a trailblazer in the field of cancer treatment and calcium disorders, with her innovative patent contributing to significant advancements in medical research. Her work exemplifies the importance of innovation in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile